Incidence, risk factors, and cardiovascular impact of hypertension in people with HIV: a secondary analysis of the REPRIEVE trial
Open Access
- 1 May 2026
- journal article
- research article
- Published by Elsevier in The Lancet HIV
- Vol. 13 (5) , e327-e337
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK040561)
- Gilead Sciences
- Instituto de Salud Carlos III (PI24/01386)
- Nutrition Obesity Research Center at Harvard (P30DK040561)
- Division of Intramural Research (U01HL123339)
- Division of Intramural Research (1UG3HL164285)
- Division of Intramural Research (U01HL123336)
- Division of Intramural Research (1U24HL164284)
- National Institute of Allergy and Infectious Diseases
- National Heart, Lung, and Blood Institute
- U.S. Department of Health and Human Services
- European Regional Development Fund
- National Institutes of Health
- Division of Intramural Research
This publication has 29 references indexed in Scilit:
- Trial Update of Pitavastatin to Prevent Cardiovascular Events in HIV InfectionNew England Journal of Medicine, 2024
- Pitavastatin to Prevent Cardiovascular Disease in HIV InfectionNew England Journal of Medicine, 2023
- HIV and cardiovascular diseaseThe Lancet HIV, 2020
- Patho-immune Mechanisms of Hypertension in HIV: a Systematic and Thematic ReviewCurrent Hypertension Reports, 2019
- First Occurrence of Diabetes, Chronic Kidney Disease, and Hypertension Among North American HIV-Infected Adults, 2000–2013Clinical Infectious Diseases, 2016
- Higher Prevalence of Hypertension in HIV-1-Infected Patients on Combination Antiretroviral Therapy Is Associated With Changes in Body Composition and Prior Stavudine ExposureClinical Infectious Diseases, 2016
- Development and Evaluation of the Nutrition Component of the Rapid Eating and Activity Assessment for Patients (REAP): A New Tool for Primary Care ProvidersJournal of Nutrition Education and Behavior, 2006
- Appropriate body-mass index for Asian populations and its implications for policy and intervention strategiesThe Lancet, 2004
- Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studiesThe Lancet, 2002
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001